These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27935279)

  • 1. Catalytic Promiscuity of O-GlcNAc Transferase Enables Unexpected Metabolic Engineering of Cytoplasmic Proteins with 2-Azido-2-deoxy-glucose.
    Shen DL; Liu TW; Zandberg W; Clark T; Eskandari R; Alteen MG; Tan HY; Zhu Y; Cecioni S; Vocadlo D
    ACS Chem Biol; 2017 Jan; 12(1):206-213. PubMed ID: 27935279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Metabolic Chemical Reporter 6-Azido-6-deoxy-glucose Further Reveals the Substrate Promiscuity of O-GlcNAc Transferase and Catalyzes the Discovery of Intracellular Protein Modification by O-Glucose.
    Darabedian N; Gao J; Chuh KN; Woo CM; Pratt MR
    J Am Chem Soc; 2018 Jun; 140(23):7092-7100. PubMed ID: 29771506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
    Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
    J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
    Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
    J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6''-Azido-6''-deoxy-UDP-N-acetylglucosamine as a glycosyltransferase substrate.
    Mayer A; Gloster TM; Chou WK; Vocadlo DJ; Tanner ME
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1199-201. PubMed ID: 21273069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate specificity provides insights into the sugar donor recognition mechanism of O-GlcNAc transferase (OGT).
    Ma X; Liu P; Yan H; Sun H; Liu X; Zhou F; Li L; Chen Y; Muthana MM; Chen X; Wang PG; Zhang L
    PLoS One; 2013; 8(5):e63452. PubMed ID: 23700425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation.
    Vocadlo DJ
    Curr Opin Chem Biol; 2012 Dec; 16(5-6):488-97. PubMed ID: 23146438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. o-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells.
    Song M; Kim HS; Park JM; Kim SH; Kim IH; Ryu SH; Suh PG
    Cell Signal; 2008 Jan; 20(1):94-104. PubMed ID: 18029144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
    Qi J; Wang R; Zeng Y; Yu W; Gu Y
    Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
    Isono T
    PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Small Molecule 2-Azido-2-deoxy-glucose Is a Metabolic Chemical Reporter of O-GlcNAc Modifications in Mammalian Cells, Revealing an Unexpected Promiscuity of O-GlcNAc Transferase.
    Zaro BW; Batt AR; Chuh KN; Navarro MX; Pratt MR
    ACS Chem Biol; 2017 Mar; 12(3):787-794. PubMed ID: 28135057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
    Yuzwa SA; Vocadlo DJ
    Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Deoxy-4-fluoro-GalNAz (4FGalNAz) Is a Metabolic Chemical Reporter of O-GlcNAc Modifications, Highlighting the Notable Substrate Flexibility of O-GlcNAc Transferase.
    Jackson EG; Cutolo G; Yang B; Yarravarapu N; Burns MWN; Bineva-Todd G; Roustan C; Thoden JB; Lin-Jones HM; van Kuppevelt TH; Holden HM; Schumann B; Kohler JJ; Woo CM; Pratt MR
    ACS Chem Biol; 2022 Jan; 17(1):159-170. PubMed ID: 34931806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates.
    Lazarus BD; Love DC; Hanover JA
    Glycobiology; 2006 May; 16(5):415-21. PubMed ID: 16434389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats.
    Rafie K; Raimi O; Ferenbach AT; Borodkin VS; Kapuria V; van Aalten DMF
    Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate and product analogues as human O-GlcNAc transferase inhibitors.
    Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM
    Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conserved threonine-rich region of the HCF-1
    Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W
    J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358
    [No Abstract]   [Full Text] [Related]  

  • 19. Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.
    Kim S; Maynard JC; Sasaki Y; Strickland A; Sherman DL; Brophy PJ; Burlingame AL; Milbrandt J
    J Neurosci; 2016 Sep; 36(37):9633-46. PubMed ID: 27629714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential regulation of nuclear UDP-N-acetylglucosaminyl transferase (OGT) by substrate availability: ability of chromatin protein to bind UDP-N-acetylglucosamine and reduce OGT-mediated O-Linked glycosylation.
    Okuyama R; Marshall S
    Biol Pharm Bull; 2004 Aug; 27(8):1293-6. PubMed ID: 15305040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.